IGC Pharma (IGC) Inventory Average (2011 - 2026)
IGC Pharma (IGC) reported Inventory Average of $350500.0 for Q1 2026, down 74.9% year-over-year from $1.4 million in Q1 2025, and down 2.77% quarter-over-quarter from $360500.0 in Q4 2025.
IGC Pharma (IGC) Inventory Average (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 15 years of Inventory Average data on file, last reported at $350500.0 in Q1 2026.
- Inventory Average for Q1 2026 came in at $350500.0, down 74.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $350500.0 (down 74.9% YoY), and the FY2026 annual result was $999000.0, up 41.5% from the prior year.
- Inventory Average fell to $350500.0 in Q1 2026 per IGC's latest filing, from $360500.0 in the prior quarter.
- Over five years, Inventory Average peaked at $2.0 million in Q1 2022 and troughed at $39500.0 in Q1 2023.
- A 5-year average of $772970.6 and a median of $703500.0 in 2025 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2024: Inventory Average sank 98.05% in 2023, then surged 2402.53% in 2024.
- A 5-year view of Inventory Average shows it stood at $105000.0 in 2022, then surged by 823.81% to $970000.0 in 2023, then declined by 23.87% to $738500.0 in 2024, then slumped by 51.18% to $360500.0 in 2025, then retreated by 2.77% to $350500.0 in 2026.
- Business Quant data shows IGC's Inventory Average at $350500.0 in Q1 2026, $360500.0 in Q4 2025, and $352500.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | 350,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 350,500.00 |
| Dec 31, 2025 | 360,500.00 |
| Sep 30, 2025 | 352,500.00 |
| Jun 30, 2025 | 703,500.00 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 738,500.00 |
| Sep 30, 2024 | 47,500.00 |
| Jun 30, 2024 | 51,500.00 |
| Mar 31, 2024 | 988,500.00 |
| Dec 31, 2023 | 970,000.00 |
| Sep 30, 2023 | 1.33 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 39,500.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 325,000.00 |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 480,000.00 |
| Sep 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | 1.74 Mn |